Leukemia Clinical Trials in Austin

Showing 921-940 of 1,100 trials

Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

NCT00082940

RATIONALE: Biological therapies, such as denileukin diftitox, may interfere with the growth of cancer cells and slow the growth of chronic lymphocytic leukemia. PURPOSE: This phase II trial is studying how well denileukin diftitox works in treating patients with fludarabine-refractory B-cell chronic lymphocytic leukemia.

Leukemia

Wake Forest University Health SciencesStarted Aug 2002

Orange, California, United States • Chicago, Illinois, United States • Vincennes, Indiana, United States +8 more locations

COMPLETEDPhase 4< 1 mile

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

NCT00519636

The purpose of this replicate study to FFU105924 is to provide data on subject preference of FFNS as compared with FPNS.

Rhinitis, Allergic, Perennial

GlaxoSmithKline360 participantsStarted Aug 2007

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Long Beach, California, United States +25 more locations

Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia

Comparator Study Evaluating Patient Experience And Preference Of FFNS vs. FPNS

Leukemia Trials in Other Cities

To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401)

ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer

Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Treosulfan/Fludarabine/Low Dose TBI as a Preparative Regimen for Children With AML/MDS Undergoing Allo HCT

A Study Of GW685698X For The Treatment Of Perennial Allergic Rhinitis In Pediatrics

Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies

Seasonal Allergic Rhinitis In Pediatric Subjects

A Study of MM-121 Combination Therapy in Patients With Advanced Non-Small Cell Lung Cancer

Perennial Allergic Rhinitis Study In Pediatric Subjects

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures

A Study of First-line Maintenance Erlotinib Versus Erlotinib at Disease Progression in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Not Progressed Following Platinum-Based Chemotherapy

LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations

A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Other Conditions in Austin